Status:
COMPLETED
Effects of Prednisolone and Infliximab on the Regulation of Urea Synthesis in Active Inflammatory Bowel Disease
Lead Sponsor:
University of Aarhus
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18-50 years
Brief Summary
Loss of total mass of muscles (catabolism) is a serious clinical problem in patients with active inflammatory bowel disease (IBD). The investigators have earlier shown that the liver plays an importan...
Eligibility Criteria
Inclusion
- Moderate to severe active inflammatory bowel disease
Exclusion
- Viral or bacterial infections
- Other chronical inflammatory diseases
- Cancer
- Other catabolic diseases
- Treatment with prednisolone or infliximab within the last 8 weeks
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00955123
Start Date
January 1 2009
End Date
December 1 2011
Last Update
October 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine V, Aarhus University Hospital
Aarhus, Denmark, 8000